E. Blind

1.7k total citations · 1 hit paper
48 papers, 1.1k citations indexed

About

E. Blind is a scholar working on Oncology, Molecular Biology and Nephrology. According to data from OpenAlex, E. Blind has authored 48 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 22 papers in Molecular Biology and 14 papers in Nephrology. Recurrent topics in E. Blind's work include Bone health and treatments (26 papers), Parathyroid Disorders and Treatments (14 papers) and Metabolism, Diabetes, and Cancer (8 papers). E. Blind is often cited by papers focused on Bone health and treatments (26 papers), Parathyroid Disorders and Treatments (14 papers) and Metabolism, Diabetes, and Cancer (8 papers). E. Blind collaborates with scholars based in Germany, United States and Netherlands. E. Blind's co-authors include Kristina Dunder, Curtis J. Rosebraugh, B. Timothy Hummer, T. Bourcier, Friedhelm Raue, H. Schmidt‐Gayk, R. Ziegler, Robert A. Nissenson, Tom Bambino and Tobias Schilling and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and Analytical Biochemistry.

In The Last Decade

E. Blind

48 papers receiving 1.1k citations

Hit Papers

Pancreatic Safety of Incretin-Based Drugs — FDA and EMA A... 2014 2026 2018 2022 2014 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pancreatic Safety of Incretin-Based Drugs — FDA and EMA Assessment
    2014 373 citations E. Blind, Kristina Dunder et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Blind Germany 15 479 433 393 239 234 48 1.1k
Yuichi Takashi Japan 18 217 0.5× 313 0.7× 157 0.4× 115 0.5× 362 1.5× 51 890
Gonzalo Díaz-Soto Spain 16 413 0.9× 136 0.3× 87 0.2× 341 1.4× 155 0.7× 62 781
J Minamikawa Japan 12 387 0.8× 551 1.3× 68 0.2× 143 0.6× 33 0.1× 26 1.1k
James W. Edmondson United States 14 264 0.6× 224 0.5× 124 0.3× 188 0.8× 105 0.4× 21 819
Hasnain Khandwala Canada 11 722 1.5× 470 1.1× 230 0.6× 141 0.6× 23 0.1× 25 1.2k
Henrik Reinhard Denmark 20 249 0.5× 202 0.5× 48 0.1× 151 0.6× 317 1.4× 29 964
Dahong Yu United States 6 257 0.5× 325 0.8× 130 0.3× 78 0.3× 19 0.1× 7 695
Karoline von Websky Germany 16 339 0.7× 164 0.4× 171 0.4× 130 0.5× 149 0.6× 25 793
Fotini Adamidou Greece 14 399 0.8× 96 0.2× 65 0.2× 204 0.9× 62 0.3× 31 634
Tomasz Francuz Poland 18 206 0.4× 315 0.7× 144 0.4× 146 0.6× 14 0.1× 64 827

Countries citing papers authored by E. Blind

Since Specialization
Citations

This map shows the geographic impact of E. Blind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Blind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Blind more than expected).

Fields of papers citing papers by E. Blind

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Blind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Blind. The network helps show where E. Blind may publish in the future.

Co-authorship network of co-authors of E. Blind

This figure shows the co-authorship network connecting the top 25 collaborators of E. Blind. A scholar is included among the top collaborators of E. Blind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Blind. E. Blind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blind, E., et al.. (2014). Pancreatic Safety of Incretin-Based Drugs — FDA and EMA Assessment. New England Journal of Medicine. 370(9). 794–797. 373 indexed citations breakdown →
2.
Blind, E., et al.. (2009). Cyclic AMP Formation in Rat Bone and Kidney Cells Is Stimulated Equally by Parathyroid Hormone-Related Protein (PTHrP) 1-34 and PTH 1-34*. Experimental and Clinical Endocrinology & Diabetes. 101(3). 150–155. 5 indexed citations
3.
Blind, E., Friedhelm Raue, Thomas R. Meinel, et al.. (2008). Diagnostische Bedeutung von Parathormone-related-Protein bei Tumorpatienten mit Hypercalcämie. DMW - Deutsche Medizinische Wochenschrift. 118(10). 330–335. 2 indexed citations
4.
Moskalenko, Vasiliy, K. Ulrichs, E. Blind, et al.. (2007). Preoperative evaluation of microencapsulated human parathyroid tissue aids selection of the optimal bioartificial graft for human parathyroid allotransplantation. Transplant International. 20(8). 688–696. 13 indexed citations
5.
Bösel, Julian, et al.. (2003). Signaling of the Human Calcium-Sensing Receptor Expressed in HEK293-Cells is Modulated by Protein Kinases A and C. Experimental and Clinical Endocrinology & Diabetes. 111(1). 21–26. 9 indexed citations
6.
7.
8.
John, Markus R., Hannes Wickert, K. Zaar, et al.. (2001). A case of neuroendocrine oncogenic osteomalacia associated with a PHEX and fibroblast growth factor-23 expressing sinusidal malignant schwannoma. Bone. 29(4). 393–402. 28 indexed citations
9.
Schilling, Tobias, Martin Pecherstorfer, E. Blind, et al.. (1996). Glucocorticoids decrease the production of parathyroid hormone-related protein in vitro but not in vivo in the walker carcinosarcoma 256 rat model. Bone. 18(4). 315–319. 9 indexed citations
10.
Blind, E.. (1994). Humoral Hypercalcemia of Malignancy: Role of Parathyroid Hormone-Related Protein. Recent results in cancer research. 137. 20–43. 1 indexed citations
11.
12.
Blind, E., Friedhelm Raue, Thomas R. Meinel, et al.. (1993). Levels of parathyroid hormone-related protein in hypercalcemia of malignancy: comparison of midregional radioimmunoassay and two-site immunoradiometric assay. Journal of Molecular Medicine. 71(1). 31–36. 10 indexed citations
13.
Blind, E., et al.. (1993). Development and Validation of an Assay to Measure Bioactivity of Human Calcitonin in Vitro Using T47D Cell Membranes. Analytical Biochemistry. 212(1). 91–97. 1 indexed citations
14.
Zink, A., E. Blind, & Friedhelm Raue. (1992). Determination of Serum Calcitonin by Immunometric Two-Site Assays in Normal Subjects and Patients with Medullary Thyroid Carcinoma. Clinical Chemistry and Laboratory Medicine (CCLM). 30(12). 831–5. 15 indexed citations
15.
Blind, E., et al.. (1992). Characterization of Antibodies Against Human N-Terminal Parathyroid Hormone by Epitope Mapping. Journal of Immunoassay. 13(1). 1–13. 4 indexed citations
16.
Blind, E., et al.. (1992). Tumor necrosis factor α inhibits the stimulatory effect of the parathyroid hormone-related protein on cyclic AMP formation in osteoblast-like cells via protein kinase C. Biochemical and Biophysical Research Communications. 182(1). 341–347. 14 indexed citations
17.
Blind, E., et al.. (1992). Circulating levels of midregional parathyroid hormone‐related protein in hypercalcaemia of malignancy. Clinical Endocrinology. 37(3). 290–297. 27 indexed citations
18.
Pfeilschifter, Johannes, et al.. (1992). Serum levels of intact parathyroid hormone and alkaline phosphatase correlate with cortical and trabecular bone loss in primary hyperparathyroidism. European Journal of Endocrinology. 127(4). 319–323. 32 indexed citations
19.
Blind, E., H. Schmidt‐Gayk, Hans‐Peter Sinn, Daniel T. O’Connor, & Friedhelm Raue. (1992). Chromogranin A as Tumor Marker in Medullary Thyroid Carcinoma. Thyroid. 2(1). 5–10. 37 indexed citations
20.
Blind, E., H. Schmidt‐Gayk, Stephan Scharla, et al.. (1988). Two-Site Assay of Intact Parathyroid Hormone in the Investigation of Primary Hyperparathyroidism and Other Disorders of Calcium Metabolism Compared With a Midregion Assay*. The Journal of Clinical Endocrinology & Metabolism. 67(2). 353–360. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuichi Takashi Breakdown of academic impact, for papers by Gonzalo Díaz-Soto Breakdown of academic impact, for papers by J Minamikawa Breakdown of academic impact, for papers by James W. Edmondson Breakdown of academic impact, for papers by Hasnain Khandwala Breakdown of academic impact, for papers by Henrik Reinhard Breakdown of academic impact, for papers by Dahong Yu Breakdown of academic impact, for papers by Karoline von Websky Breakdown of academic impact, for papers by Fotini Adamidou Breakdown of academic impact, for papers by Tomasz Francuz
Rankless by CCL
2026